| ■ J&J Will Revamp Plants in Wake of Recall | 2010.05.28 |
| Following a massive recall of its children's medicines, Johnson & Johnson says it plans to restructure its manufacturing operations in an attempt to improve its tarnished image. &J's McNeil Consumer Healthcare unit -- in an announcement to employees on its Web site Tuesday -- said it has hired an outside consulting firm to improve its manufacturing operations, which led to the recent recall of Tylenol and other medications. The plan will be presented to the U.S. Food and Drug Administration by mid-July, the company said, the Associated Press reported. "McNeil is taking steps to bring its operation back to a level of quality that Johnson & Johnson demands of its companies, and that the public rightly expects of us," the statement reads. The latest recall has drawn the ire of lawmakers. The chairman of the Senate's health committee on Monday wrote a letter to the FDA, requesting more information about the recall. Officials are also looking into procedures at a plant that makes sterilization tools, the AP said. |